WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

S SENSORY ORGANS

A formulation approved both for use in the eye/ear is classified in S03. Formulations approved for eye, ear and nose are also classified in S03. Formulations only licensed for use in the eye or the ear are classified in S01 and S02, respectively.


S01 OPHTHALMOLOGICALS

Most of the drugs in this group are topical preparations. Systemic preparations with clear ophthalmological indications are also classified in this group.
Small amounts of antiseptics in eye preparations do not influence the classification, e.g. benzalconium.
See also S03 - Ophthalmological and otological preparations.

DDDs have been assigned for antiglaucoma preparations only.

S02 OTOLOGICALS

Small amounts of antiseptics in otological preparations do not influence the classification, e.g. benzalconium.
See also S03 - Ophthalmological and otological preparations.

No DDDs are assigned in this group.

S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS

This group comprises preparations which can be used in both eye and ear.
Formulations approved for eye, ear and nose should also be classified in S03.
Small amounts of antiseptics (e.g. benzalconium) do not influence the classification.

No DDDs are assigned in this group.

Last updated: 2024-01-26